Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05156437 · ClinicalTrials.gov registry record · Phase 4
Postoperative Antibiotic Management Duration Following Surgery for Intravenous Drug Abuse (IVDA) Endocarditis (OPTIMAL)
A Phase 4 study, sponsored by West Virginia University.
- Terminated
- Registry status
- Phase 4
- Development phase
- 5
- Enrollment target
NCT05156437 is a Phase 4 study that was terminated before completion, run by West Virginia University. The registered enrollment target is 5 participants.
The verdict
NCT05156437, a Phase 4 study, was terminated before completion, sponsored by West Virginia University.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 5 participants
- Enrollment target
Study Summary
The purpose of this study is to determine the safety and compliance of initial intravenous (IV) antibiotics followed by oral antibiotic therapy following uncomplicated IVDA endocarditis. Endocarditis has a high rate of sickness and death, involves a long hospitalization and a long-term use of IV antibiotics necessitating six (6) weeks of in-patient hospital stay, and comes with a high cost.
Interventions
- DRUG Amoxycillin, Cefalexin, Dicloxacillin, Linezolid, Levofloxacin, Rifampicin
- DRUG Ampicillin, Oxacillin, Vancomycin, Daptomycin, Ceftriaxone, Cefepime, Ceftaroline
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5 participants |
| Start Date | 2022-03-16 |
| Est. Completion | 2024-10-31 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05156437
The ClinicalTrials.gov registry entry for NCT05156437 describes a study currently listed as terminated, categorized as Phase 4. The registered enrollment target is 5 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is West Virginia University, which has 122 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Amoxycillin, Cefalexin, Dicloxacillin, Linezolid, Levofloxacin, Rifampicin is the first listed.
NCT05156437 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05156437 about?
NCT05156437 is a clinical study titled "Postoperative Antibiotic Management Duration Following Surgery for Intravenous Drug Abuse (IVDA) Endocarditis (OPTIMAL)". The purpose of this study is to determine the safety and compliance of initial intravenous (IV) antibiotics followed by oral antibiotic therapy following uncomplicated IVDA endocarditis. Endocarditis has a high rate of sickness and death, involves a long hospitalization and a long-term use of IV ant...
What is the current status of trial NCT05156437?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 5 participants. The study started on 2022-03-16. Estimated completion is 2024-10-31.
What interventions are being tested in trial NCT05156437?
The interventions under investigation include: Amoxycillin, Cefalexin, Dicloxacillin, Linezolid, Levofloxacin, Rifampicin (DRUG), Ampicillin, Oxacillin, Vancomycin, Daptomycin, Ceftriaxone, Cefepime, Ceftaroline (DRUG).
Who is sponsoring clinical trial NCT05156437?
This trial is sponsored by West Virginia University, which has 122 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.